89bio Inc (ETNB)
8.26
+0.01
(+0.12%)
USD |
NASDAQ |
Apr 26, 16:00
8.26
0.00 (0.00%)
After-Hours: 20:00
89bio 1 Year Total Returns (Daily): -46.74% for April 26, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 26, 2024 | -46.74% |
April 25, 2024 | -46.60% |
April 24, 2024 | -45.35% |
April 23, 2024 | -46.55% |
April 22, 2024 | -44.22% |
April 19, 2024 | -48.17% |
April 18, 2024 | -47.98% |
April 17, 2024 | -44.75% |
April 16, 2024 | -39.63% |
April 15, 2024 | -38.85% |
April 12, 2024 | -30.60% |
April 11, 2024 | -29.24% |
April 10, 2024 | -26.86% |
April 09, 2024 | -27.09% |
April 08, 2024 | -27.83% |
April 05, 2024 | -26.60% |
April 04, 2024 | -28.19% |
April 03, 2024 | -28.20% |
April 02, 2024 | -30.53% |
April 01, 2024 | -29.55% |
March 28, 2024 | -30.26% |
March 27, 2024 | -30.83% |
March 26, 2024 | -31.16% |
March 25, 2024 | -30.30% |
March 22, 2024 | -15.94% |
Date | Value |
---|---|
March 21, 2024 | 4.76% |
March 20, 2024 | -3.74% |
March 19, 2024 | -4.18% |
March 18, 2024 | 1.29% |
March 15, 2024 | 5.71% |
March 14, 2024 | -10.57% |
March 13, 2024 | 5.47% |
March 12, 2024 | 7.25% |
March 11, 2024 | 7.42% |
March 08, 2024 | -3.00% |
March 07, 2024 | -0.31% |
March 06, 2024 | -13.67% |
March 05, 2024 | -17.22% |
March 04, 2024 | -2.82% |
March 01, 2024 | -9.40% |
February 29, 2024 | -15.79% |
February 28, 2024 | -13.66% |
February 27, 2024 | -12.58% |
February 26, 2024 | -14.83% |
February 23, 2024 | -17.12% |
February 22, 2024 | -22.59% |
February 21, 2024 | -24.69% |
February 20, 2024 | -29.21% |
February 16, 2024 | -28.49% |
February 15, 2024 | -24.69% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-91.96%
Minimum
Apr 29 2022
764.6%
Maximum
May 09 2023
39.80%
Average
-22.27%
Median
Nov 15 2023
1 Year Total Returns (Daily) Benchmarks
Madrigal Pharmaceuticals Inc | -37.08% |
Akero Therapeutics Inc | -55.73% |
Viking Therapeutics Inc | 280.1% |
Galectin Therapeutics Inc | 96.02% |
Terns Pharmaceuticals Inc | -61.31% |